McGann PT - Search Results

1

US News & World Report and quality metrics: Inclusion of sickle cell disease is a matter of equity.

Power-Hays A, Dandoy CE, Lorts A, Perentesis JP, Unaka N, Ware RE, McGann PT. Power-Hays A, et al. Among authors: mcgann pt. Pediatr Blood Cancer. 2022 Aug;69(8):e29679. doi: 10.1002/pbc.29679. Epub 2022 Apr 20. Pediatr Blood Cancer. 2022. PMID: 35441787 No abstract available.

2

IgA-mediated autoimmune hemolytic anemia in an infant.

McGann PT, McDade J, Mortier NA, Combs MR, Ware RE. McGann PT, et al. Pediatr Blood Cancer. 2011 May;56(5):837-9. doi: 10.1002/pbc.22932. Epub 2010 Dec 22. Pediatr Blood Cancer. 2011. PMID: 21370419

3

Hydroxyurea for sickle cell anemia: what have we learned and what questions still remain?

McGann PT, Ware RE. McGann PT, et al. Curr Opin Hematol. 2011 May;18(3):158-65. doi: 10.1097/MOH.0b013e32834521dd. Curr Opin Hematol. 2011. PMID: 21372708 Free PMC article. Review.

4

Chromosome damage and repair in children with sickle cell anaemia and long-term hydroxycarbamide exposure.

McGann PT, Howard TA, Flanagan JM, Lahti JM, Ware RE. McGann PT, et al. Br J Haematol. 2011 Jul;154(1):134-40. doi: 10.1111/j.1365-2141.2011.08698.x. Epub 2011 May 4. Br J Haematol. 2011. PMID: 21542824 Free PMC article.

5

Genotoxicity associated with hydroxyurea exposure in infants with sickle cell anemia: results from the BABY-HUG Phase III Clinical Trial.

McGann PT, Flanagan JM, Howard TA, Dertinger SD, He J, Kulharya AS, Thompson BW, Ware RE; BABY HUG Investigators. McGann PT, et al. Pediatr Blood Cancer. 2012 Aug;59(2):254-7. doi: 10.1002/pbc.23365. Epub 2011 Oct 19. Pediatr Blood Cancer. 2012. PMID: 22012708 Free PMC article. Clinical Trial.

6

A novel laboratory technique demonstrating the influences of RHD zygosity and the RhCcEe phenotype on erythrocyte D antigen expression.

McGann PT, Despotovic JM, Howard TA, Ware RE. McGann PT, et al. Am J Hematol. 2012 Mar;87(3):266-71. doi: 10.1002/ajh.22254. Epub 2011 Nov 25. Am J Hematol. 2012. PMID: 22121029 Free PMC article.

7

Current management of sickle cell anemia.

McGann PT, Nero AC, Ware RE. McGann PT, et al. Cold Spring Harb Perspect Med. 2013 Aug 1;3(8):a011817. doi: 10.1101/cshperspect.a011817. Cold Spring Harb Perspect Med. 2013. PMID: 23709685 Free PMC article.

8

RHD zygosity predicts degree of platelet response to anti-D immune globulin treatment in children with immune thrombocytopenia.

Despotovic JM, McGann PT, Smeltzer M, Aygun B, Ware RE. Despotovic JM, et al. Among authors: mcgann pt. Pediatr Blood Cancer. 2013 Sep;60(9):E106-8. doi: 10.1002/pbc.24574. Epub 2013 May 27. Pediatr Blood Cancer. 2013. PMID: 23712954 Clinical Trial.

9

A prospective newborn screening and treatment program for sickle cell anemia in Luanda, Angola.

McGann PT, Ferris MG, Ramamurthy U, Santos B, de Oliveira V, Bernardino L, Ware RE. McGann PT, et al. Am J Hematol. 2013 Dec;88(12):984-9. doi: 10.1002/ajh.23578. Epub 2013 Oct 15. Am J Hematol. 2013. PMID: 24038490 Free article.

10

Hydroxyurea Therapy for Children With Sickle Cell Anemia in Sub-Saharan Africa: Rationale and Design of the REACH Trial.

McGann PT, Tshilolo L, Santos B, Tomlinson GA, Stuber S, Latham T, Aygun B, Obaro SK, Olupot-Olupot P, Williams TN, Odame I, Ware RE; REACH Investigators. McGann PT, et al. Pediatr Blood Cancer. 2016 Jan;63(1):98-104. doi: 10.1002/pbc.25705. Epub 2015 Aug 14. Pediatr Blood Cancer. 2016. PMID: 26275071 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters